Phio Pharmaceuticals
PHIO
#10804
Rank
NZ$21.39 M
Marketcap
NZ$1.84
Share price
-3.54%
Change (1 day)
-48.77%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2026 (TTM): -NZ$18.74 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$14.7 Million a decrease over its 2024 earnings that were of -NZ$12.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$18.74 Million27.45%
2025 -NZ$14.7 Million21.65%
2024 -NZ$12.09 Million-33.96%
2023 -NZ$18.3 Million-5.7%
2022 -NZ$19.4 Million-13.6%
2021 -NZ$22.45 Million51.09%
2020 -NZ$14.86 Million-1.28%
2019 -NZ$15.06 Million21.03%
2018 -NZ$12.44 Million-53.1%
2017 -NZ$26.52 Million74.49%
2016 -NZ$15.2 Million-12.02%
2015 -NZ$17.28 Million16.17%
2014 -NZ$14.87 Million-57.95%
2013 -NZ$35.36 Million62.45%
2012 -NZ$21.77 Million0.87%
2011 -NZ$21.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.39 Billion 1,994.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$30.68 Million 66.08%๐Ÿ‡บ๐Ÿ‡ธ USA